Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
King International InvestmentHKSE:00928 -4.85% Pretax Margin % is -3.48% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 201 Medical Diagnostics & Research companies, King International Investment ranks better than 63.68% on this metric.
The historical rank and industry rank for King International Investment's Pretax Margin % or its related term are showing as below:
HKSE:00928'
s Pretax Margin % Range Over the Past 10 Years
Min: -190.43 Med: -38.1 Max: 10.21
Current: 4.78
HKSE:00928's Pretax Margin % is ranked better than 63.68% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: -4.31
vs HKSE:00928: 4.78
King International Investment (HKSE:00928) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
King International Investment Pretax Margin % Related Terms
King International Investment Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
King International Investment Pretax Margin % Chart
HKSE:00928 vs TMO, DHR, IDXX: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, King International Investment's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
King International Investment Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where King International Investment's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
King International Investment (HKSE:00928) has a Pretax Margin % of -3.48% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on King International Investment and its competitors. According to the industry distribution chart, King International Investment ranks #73 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 36.3%.
Is King International Investment's Pretax Margin % too high?
King International Investment's current Pretax Margin % is -3.48%. Based on the distribution chart, King International Investment ranks #73 out of 201 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does King International Investment's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, King International Investment ranks #73 out of 201 companies for Pretax Margin %. This puts King International Investment in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on King International Investment and its competitors. King International Investment's current Pretax Margin % is -3.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is King International Investment stock overvalued right now?
Based on GuruFocus' analysis, King International Investment (HKSE:00928) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.10 — trading 145% above its estimated fair value. The current Pretax Margin % is -3.48%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For King International Investment (HKSE:00928), the current Pretax Margin % is -3.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
King International Investment Ltd is an investment holding company. Its operating segments include healthcare products and services, money lending, and liquor sales, with the majority of revenue generated from the liquor sales segment. The group provides genetic testing and develops domestic healthcare equipment services. Leveraging its strengths, the group integrates health data analysis software with healthcare equipment to offer new healthcare services and products. Geographically, it derives the majority of its revenue from the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00928 has been successfully added to your 
